A citation-based method for searching scientific literature

S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
Times Cited: 227







List of co-cited articles
737 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
31

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
29

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
268
25

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
483
22

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
229
22

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
20

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
298
19

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
460
17

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
184
17

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
245
17

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
160
15

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
145
15

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Catherine S Manno, Kelly M Axsom, Timothy Andrews, John K Choi, Barbara H Greenbaum, Joseph M McMann, Kathleen E Sullivan, Susan F Travis, Stephan A Grupp. Blood 2005
101
14

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Faith Dugan, Janet K Dale, Joie Davis, Jean Tretler, John K Hurley, Thomas Fleisher, Jennifer Puck, Stephen E Straus. Br J Haematol 2005
75
18

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
142
13

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
144
12

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
U Ramenghi, S Bonissoni, G Migliaretti, S DeFranco, F Bottarel, C Gambaruto, D DiFranco, R Priori, F Conti, I Dianzani,[...]. Blood 2000
80
15

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003
148
12

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
91
13

Autoimmune lymphoproliferative syndrome.
Michael C Sneller, Janet K Dale, Stephen E Straus. Curr Opin Rheumatol 2003
63
17

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
342
10

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
113
10

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
128
10

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
R M Siegel, F K Chan, H J Chun, M J Lenardo. Nat Immunol 2000
315
10

Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Austen Worth, Adrian J Thrasher, H Bobby Gaspar. Br J Haematol 2006
107
10

Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity.
Peter D Hughes, Gabrielle T Belz, Karen A Fortner, Ralph C Budd, Andreas Strasser, Philippe Bouillet. Immunity 2008
182
10

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Susan Price, Katie Perkins, Patricia Aldridge, Jean Tretler, Joie Davis, Janet K Dale, Fred Gill, Kip R Hartman, Linda C Stork,[...]. Pediatr Blood Cancer 2009
55
18

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
David T Teachey, Robert Greiner, Alix Seif, Edward Attiyeh, Jack Bleesing, John Choi, Catherine Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen,[...]. Br J Haematol 2009
101
10


Role of inherited defects decreasing Fas function in autoimmunity.
Umberto Dianzani, Annalisa Chiocchetti, Ugo Ramenghi. Life Sci 2003
39
23

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
74
12

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Dana A Obzut, Kelly Axsom, John K Choi, Kelly C Goldsmith, Junior Hall, Jessica Hulitt, Catherine S Manno, John M Maris, Nicholas Rhodin,[...]. Blood 2006
62
14

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
59
15

The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
Maria Francesca Campagnoli, Letizia Garbarini, Paola Quarello, Emanuela Garelli, Adriana Carando, Valentina Baravalle, Alessandra Doria, Alessandra Biava, Annalisa Chiocchetti, Angelo Rosolen,[...]. Haematologica 2006
35
25

Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction.
Ashley E Weant, Ryan D Michalek, Islam U Khan, Beth C Holbrook, Mark C Willingham, Jason M Grayson. Immunity 2008
150
9

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
91
9

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
Iusta Caminha, Thomas A Fleisher, Ronald L Hornung, Janet K Dale, Julie E Niemela, Susan Price, Joie Davis, Katie Perkins, Kennichi C Dowdell, Margaret R Brown,[...]. J Allergy Clin Immunol 2010
54
16


Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
Irina Maric, Stefania Pittaluga, Janet K Dale, Julie E Niemela, Georges Delsol, Judith Diment, Juan Rosai, Mark Raffeld, Jennifer M Puck, Stephen E Straus,[...]. Am J Surg Pathol 2005
78
10

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
8


Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
Jack Hutcheson, John C Scatizzi, Akbar M Siddiqui, G Kenneth Haines, Tianfu Wu, Quan-Zhen Li, Laurie S Davis, Chandra Mohan, Harris Perlman. Immunity 2008
153
8

Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim.
David A Hildeman, Yanan Zhu, Thomas C Mitchell, Philippe Bouillet, Andreas Strasser, John Kappler, Philippa Marrack. Immunity 2002
449
8

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
M Lenardo, K M Chan, F Hornung, H McFarland, R Siegel, J Wang, L Zheng. Annu Rev Immunol 1999
776
8

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Jutte van der Werff Ten Bosch, Peter Schotte, Alice Ferster, Nadira Azzi, Thomas Boehler, Geneviève Laurey, Mikko Arola, Christian Demanet, Rudi Beyaert, Kris Thielemans,[...]. Br J Haematol 2002
31
22

Causes and consequences of the autoimmune lymphoproliferative syndrome.
V Koneti Rao, Stephen E Straus. Hematology 2006
45
15

Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Pierre Bobé, Danielle Bonardelle, Karim Benihoud, Paule Opolon, Mounira K Chelbi-Alix. Blood 2006
70
10

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Lilia L Bi, George Pan, T Prescott Atkinson, Lixin Zheng, Janet K Dale, Christopher Makris, Vishnu Reddy, Jay M McDonald, Richard M Siegel, Jennifer M Puck,[...]. BMC Med Genet 2007
47
14

Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.
Peter B Stranges, Jessica Watson, Cristie J Cooper, Caroline-Morgane Choisy-Rossi, Austin C Stonebraker, Ryan A Beighton, Heather Hartig, John P Sundberg, Stein Servick, Gunnar Kaufmann,[...]. Immunity 2007
244
7

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.
José C Crispín, Mohamed Oukka, George Bayliss, Robert A Cohen, Christine A Van Beek, Isaac E Stillman, Vasileios C Kyttaris, Yuang-Taung Juang, George C Tsokos. J Immunol 2008
485
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.